Toward a CO2-free ethylene oxide process: Homogeneous ethylene oxide in gas-expanded liquids

Among industrial chemical processes, ethylene oxide manufacture emits the largest amount of CO₂ (∼2-3 million tons/yr), as byproduct from the burning of both the ethylene (feed) and ethylene oxide. Further, the conventional silver-based catalytic process presents safety challenges due to the formation of explosive ethylene oxide/O₂ mixtures in the gas phase. By judicious choice of the catalyst (methyltrioxorhenium), oxidant (H₂O₂) and reaction medium (methanol/water), a homogeneous liquid phase catalytic system has been demonstrated that eliminates CO₂ formation while producing ethylene oxide at >90% selectivity at near-ambient temperatures. Given its high volatility, the ethylene oxide is easily recovered from the reaction phase by distillation. The vicinity of the gaseous ethylene feed to its critical temperature (9 °C) is exploited to significantly increase its solubility in the liquid reaction phase by facile compression beyond the critical pressure of ethylene (∼50 bar). Since H₂O₂ is stable at typical reaction temperatures (40 °C or less), potentially explosive ethylene oxide/O₂ mixtures are avoided in the gas phase. In addition to the potential of arresting the carbon footprint of a large-scale industrial process, the demonstrated process concept shows how gas-expanded liquids can be generally exploited in homogeneous catalysis to enhance productivity.     

Digital watermarking: from concepts to real-time video applications

Digital watermarking has been increasingly applied to hide information in digital multimedia data, thus enlisting the watermarking technology in the difficult fight against intellectual property rights infringement. The authors have developed a secure, robust watermarking algorithm and applied it in digital streaming MPEG-2 format video-the format of choice in the broadcast and video stock industry     

Using sequence logos and information analysis of Lrp DNA binding sites to investigate discrepanciesbetween natural selection and SELEX

In vitro experiments that characterize DNA-protein interactions by artificial selection, such as SELEX,are often performed with the assumption that the experimental conditions are equivalent to natural ones. To test whether SELEX gives natural results, we compared sequence logos composed from naturally occurring leucine-responsive regulatory protein (Lrp) binding sites with those composed from SELEX-generated binding sites. The sequence logos were significantly different, indicating that the binding conditions are disparate. A likely explanation is that the SELEX experiment selected for a dimeric or trimeric Lrp complex bound to DNA. In contrast, natural sites appear to be bound by a monomer. This discrepancy suggests that in vitro selections do not necessarily give binding site sets comparable with the natural binding sites.     

Using fluorescence-based human androgen receptor gene assay to analyze the clonality of microdissected dendritic cell tumors

The AGT1 permease is a alpha-glucoside-H+ symporter responsible for the active transport of maltose, trehalose, maltotriose, alpha-methylglucoside, melezitose and sucrose. In wild-type as well as in MAL constitutive strains, alpha-methylglucoside seemed to be the best inducer of transport activity, while trehalose had no inducing effect. Based on the initial rates of transport it seems that the sugar preferentially transported by this permease is trehalose, followed by sucrose.     

Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies

Creatine (Cr) and cyclocreatine (cyCr) have been shown to inhibit the growth of a variety of human and murine tumours. The purpose of this study was to evaluate the anti-tumour effect of these molecules in relation to drug accumulation, energy metabolism, tumour water accumulation and toxicity. Nude mice carrying a human colon adenocarcinoma (LS174T) with a creatine kinase (CK) activity of 2.12 units mg(-1) protein were fed Cr (2.5% or 5%) or cyCr (0.025%, 0.1% or 0.5%) for 2 weeks and compared with controls fed standard diet. Cr concentrations of 2.5% and 5% significantly inhibited tumour growth, as did 0.1% and 0.5% cyCr. In vivo 31P magnetic resonance spectroscopy (MRS) after 2 weeks of treatment showed an increase in [phosphocreatine (PCr)+phosphocyclocreatine (PcyCr)]/nucleoside triphosphate (NTP) with increasing concentrations of dietary Cr and cyCr, without changes in absolute NTP contents. The antiproliferative effect of the substrates of CK was not related to energy deficiency but was associated with acidosis. Intratumoral substrate concentrations (measured by 1H-MRS) of 4.8 micromol g(-1) wet weight Cr (mice fed 2.5% Cr) and 6.2 micromol g(-1) cyCr (mice fed 0.1% cyCr) induced a similar decrease in growth rate, indicating that both substrates were equally potent in tumour growth inhibition. The best correlant of growth inhibition was the total Cr or (cyCr+Cr) concentrations in the tissue. In vivo, these agents did not induce excessive water accumulation and had no systemic effects on the mice (weight loss, hypoglycaemia) that may have caused growth inhibition.